Clinically relevant copy number variations detected in cerebral palsy

Nat Commun. 2015 Aug 3:6:7949. doi: 10.1038/ncomms8949.


Cerebral palsy (CP) represents a group of non-progressive clinically heterogeneous disorders that are characterized by motor impairment and early age of onset, frequently accompanied by co-morbidities. The cause of CP has historically been attributed to environmental stressors resulting in brain damage. While genetic risk factors are also implicated, guidelines for diagnostic assessment of CP do not recommend for routine genetic testing. Given numerous reports of aetiologic copy number variations (CNVs) in other neurodevelopmental disorders, we used microarrays to genotype a population-based prospective cohort of children with CP and their parents. Here we identify de novo CNVs in 8/115 (7.0%) CP patients (∼1% rate in controls). In four children, large chromosomal abnormalities deemed likely pathogenic were found, and they were significantly more likely to have severe neuromotor impairments than those CP subjects without such alterations. Overall, the CNV data would have impacted our diagnosis or classification of CP in 11/115 (9.6%) families.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Cerebral Palsy / genetics*
  • Chromosome Aberrations*
  • Chromosomes, Human / genetics*
  • Cohort Studies
  • DNA Copy Number Variations / genetics*
  • Female
  • Genotype
  • Humans
  • Male
  • Parents*
  • Prospective Studies